Ilyes Ioana, Boariu Marius, Rusu Darian, Iorio-Siciliano Vincenzo, Vela Octavia, Boia Simina, Radulescu Viorelia, Șurlin Petra, Jentsch Holger, Lodin Alexandru, Stratul Stefan-Ioan
Department of Periodontology, Faculty of Dental Medicine, Anton Sculean Research Center for Periodontal and Peri-Implant Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Endodontics, Faculty of Dental Medicine, TADERP Research Center, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Antibiotics (Basel). 2024 May 9;13(5):430. doi: 10.3390/antibiotics13050430.
To improve the clinical and microbiological outcomes of non-surgical mechanical periodontal therapy, the adjunctive use of antimicrobials has been utilized in treating moderate-to-severe periodontitis. In our study, the retrospective design included previously collected health-related patient data, obtained from the printed and digital charts of patients who received systemic or local antibiotic adjuncts to SI (subgingival instrumentation). A total of 34 patients (diagnosed with generalized Stage III/IV periodontitis) met the inclusion and exclusion criteria and were evaluated. The samples were tested for the following bacterial strains: (), (), (), (), and (). The inter-group comparisons of the bacterial species did not show statistically significant differences between groups. The present study aimed to evaluate the clinical effects after SI and the adjunctive use of systemically administered (SA) AMX (amoxicillin) + MET (metronidazole) (administered for 7 days), with locally delivered (LDD) piperacillin + tazobactam in step 2 of periodontal therapy. Results: Overall, all parameters were improved in the groups, with a significant difference in inter-group comparison regarding the full-mouth bleeding score (FMBS) ( < 0.05) in favor of the SA group, and the -value < 0.05 was considered to be statistically significant. Statistically significant PPD (probing pocket depth) reductions and CAL (clinical attachment level) gains were observed in both groups at the 3-month follow-up. In conclusion, within the limitations, the outcomes of this study suggest that SI, with adjunctive local or systemic antibiotic therapy, provided comparable clinical improvements. Systemic AMX + MET protocols were more efficacious with regard to the reduction in FMBS. Follow-up studies with larger patient numbers are needed to further investigate this effect.
为改善非手术机械性牙周治疗的临床和微生物学效果,抗菌药物的辅助使用已被用于治疗中重度牙周炎。在我们的研究中,回顾性设计纳入了先前收集的与健康相关的患者数据,这些数据来自接受全身或局部抗生素辅助龈下器械治疗(SI)患者的纸质和电子病历。共有34例(诊断为广泛性III/IV期牙周炎)患者符合纳入和排除标准并接受评估。对样本检测以下细菌菌株:()、()、()、()和()。各细菌种类的组间比较未显示出组间有统计学显著差异。本研究旨在评估牙周治疗第二步中龈下器械治疗(SI)联合全身应用(SA)阿莫西林(AMX)+甲硝唑(MET)(用药7天)和局部应用(LDD)哌拉西林+他唑巴坦后的临床效果。结果:总体而言,两组所有参数均有改善,组间比较时全口出血评分(FMBS)有显著差异(<0.05),SA组更优,P值<0.05被认为具有统计学显著性。在3个月随访时,两组均观察到探诊深度(PPD)有统计学显著性降低和临床附着水平(CAL)增加。总之,在本研究的局限性范围内,研究结果表明龈下器械治疗联合局部或全身抗生素治疗可带来相当的临床改善。全身应用AMX+MET方案在降低FMBS方面更有效。需要更多患者数量的随访研究来进一步探究这种效果。